Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
iPass (NASDAQ:IPAS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $0.25 and last traded at $0.26, with a volume of 1008220 shares changing hands. The stock had previously closed at $0.27.
IPAS has been the subject of a number of analyst reports. Maxim Group set a $2.00 price target on iPass and gave the company a “buy” rating....More>>>
Rockwell Collins, Inc. (NYSE:COL) will be acquired by United Technologies Corporation (NYSE:UTX) in a $23 billion cash and stock deal. The transaction prices COL stock at $140 a share, an 18% premium to where it traded last month when the deal initially made news.
In what will be the biggest aerospace deal in history, industry watchers expect it to reshape....More>>>
"Sell everything," came the phone call on a January 1981 night… A crash was coming. The next morning, stocks dropped 2.5%. The market headed in that direction for most of the year, losing 9.7%. It was masterful crystal-ball gazing by market commentator Joe Granville. He would later say: "The market told me, 'Sell.' And we do what the market tells us to;....More>>>
Most businesses posting rapid expansion right now will not be able to maintain that level of growth over time. On the other hand, there will be standouts — the rare companies with the right makeup and competitive advantages to capitalize on market trends and repeatedly take their businesses to the next level.
Having even a few of these companies working in your favor over the long term....More>>>
The management of regulatory affairs essentially contributes to the overall success of new drug development – both at early pre-marketing stages and at all times post-marketing. This means that a biotech or pharma company’s regulatory affairs personnel will be heavily involved in all stages of new drug development both prior to and after an FDA approval.
There have been some macroeconomic signs that America's housing boom is starting to show signs of fatigue, but those figures haven't really shown up in the earnings reports of most homebuilders. The one exception is Beazer Homes USA (NYSE:BZH). While most companies are still showing strong home
Sturm Ruger & Company Inc (NYSE:RGR) announced a quarterly dividend on Wednesday, August 1st, RTT News reports. Stockholders of record on Friday, August 17th will be paid a dividend of 0.34 per share on Friday, August 31st. This represents a $1.36 dividend on an annualized basis and a dividen
Media conglomerate Vivendi SA ADR (NASDAQOTH:VIVHY) announced its second-quarter/first-half results on July 30, and reported strong adjusted net income growth, while also seeing its balance sheet grow steadily on the back of solid cash flows and the proceeds of selling its stake in Ubisoft earli
Tanger Factory Outlet Centers Inc.(NYSE:SKT)announced solid second-quarter 2018 results on Tuesday after the market closed, detailing flat top-line growth but also continued high occupancy rates, an increased dividend, and a reiteration of full-year guidance.